Comparison · NCT00572897-sae
Sibling Donor vs Unrelated Donor: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Sibling Donor vs Unrelated Donor: serious adverse events. Trial comparisons, record NCT00572897-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00572897-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.25 | 0.133 | 0.421 | wilson | |
| Risk in group 2 | 0.676 | 0.508 | 0.809 | wilson | |
| Risk difference, group 1 minus group 2 | -0.426 | -0.603 | -0.187 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.37 | 0.194 | 0.703 | log | |
| Odds ratio, group 1 over group 2 | 0.159 | 0.0544 | 0.467 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Sibling Donor than on Unrelated Donor | 2.34 | 1.66 | 5.36 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Sibling Donor | Patients received a stem cell transplant from sibling | 8 | 32 | EG000 |
| Group 2 | Unrelated Donor | Patients received a stem cell transplant from an unrelated donor | 23 | 34 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
Source ClinicalTrials.gov
Trial
- Title
- Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
- NCT number
- NCT00572897
- Phases
- PHASE2
- Conditions
- Myelofibrosis
- Interventions
- Fludarabine, Melphalan +/- ATG
- Lead sponsor
- John Mascarenhas
- Results first posted
- 2016-05-02
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00572897?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00572897-sae